Advancing probiotic delivery in cancer therapy: nanocarrier innovations for enhanced viability, targeted action, and clinical translation
Crossref DOI link: https://doi.org/10.1186/s44301-025-00018-0
Published Online: 2025-11-27
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Rahmati, Farzad https://orcid.org/0000-0002-0819-3404
Text and Data Mining valid from 2025-11-27
Version of Record valid from 2025-11-27
Article History
Received: 19 October 2025
Revised: 14 November 2025
Accepted: 25 November 2025
First Online: 27 November 2025
Declarations
:
: The authors declare no competing interests.